Immunotherapy achieves breakthrough result in patients with Hodgkin lymphoma
A therapy that liberates the immune system to attack cancer cells drove Hodgkin lymphoma (HL) into complete or partial remission in fully 87 percent of patients with resistant forms of the disease who participated in an early-phase ...
Dec 6, 2014
0
0